Stephanie Lee
#124,216
Most Influential Person Now
American hematologist and physician scientist
Stephanie Lee 's AcademicInfluence.com Rankings
Stephanie Lee philosophy Degrees
Philosophy
#5902
World Rank
#8833
Historical Rank
Logic
#3114
World Rank
#4225
Historical Rank
Download Badge
Philosophy
Stephanie Lee 's Degrees
- Doctorate Medicine Harvard University
Why Is Stephanie Lee Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephanie J. Lee is an American haematologist and physician scientist who is Professor and Associate Director at the Fred Hutchinson Cancer Research Center. Lee works to improve the lives of blood stem cell transplant and bone marrow patients by better understanding the chronic form of graft-versus-host disease. Lee is the former President of the American Society of Hematology.
Stephanie Lee 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. (2005) (3030)
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. (2005) (2933)
- A phase 2 study of bortezomib in relapsed, refractory myeloma. (2003) (2631)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (2015) (2244)
- National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. (2005) (1947)
- American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. (2006) (1829)
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia (2006) (1325)
- High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. (2007) (1136)
- Peripheral-blood stem cells versus bone marrow from unrelated donors. (2012) (698)
- A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (2004) (620)
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. (2011) (525)
- Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (2002) (512)
- Risk factors for acute GVHD and survival after hematopoietic cell transplantation. (2012) (511)
- Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. (2002) (493)
- Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation (2017) (470)
- Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. (2005) (450)
- Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. (2006) (440)
- Rituximab for steroid-refractory chronic graft-versus-host disease. (2006) (411)
- Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. (2004) (384)
- Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. (2006) (346)
- Double unrelated reduced-intensity umbilical cord blood transplantation in adults. (2007) (331)
- JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance (2005) (314)
- Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. (2012) (305)
- A disease risk index for patients undergoing allogeneic stem cell transplantation. (2012) (305)
- Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. (2010) (303)
- Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. (2011) (303)
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. (2004) (301)
- Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. (2006) (299)
- Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. (2003) (299)
- Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (2015) (283)
- Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. (2006) (282)
- Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and (2006) (275)
- Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. (2015) (264)
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report (2006) (261)
- X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis. (2005) (249)
- Current Use and Trends in Hematopoietic Cell Transplantation in the United States. (2017) (248)
- The clinical phenotype of wild‐type, heterozygous, and homozygous JAK2V617F in polycythemia vera (2006) (247)
- Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. (2016) (243)
- Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. (2014) (241)
- Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. (2013) (226)
- Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. (2009) (226)
- Current Use and Trends in Hematopoietic Cell Transplantation in the United States. (2017) (216)
- Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. (2014) (215)
- Recognizing and managing chronic graft-versus-host disease. (2008) (214)
- Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. (2002) (213)
- Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. (2007) (208)
- Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. (2013) (205)
- Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. (2011) (203)
- HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. (2011) (201)
- Prevalence of hematopoietic cell transplant survivors in the United States. (2013) (200)
- Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. (2005) (199)
- EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment (2018) (196)
- NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. (2015) (189)
- Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. (2004) (187)
- Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. (2003) (184)
- Classification systems for chronic graft-versus-host disease. (2017) (176)
- Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. (2010) (175)
- Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. (2002) (174)
- Enhancing physician-patient communication. (2002) (169)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. (2015) (164)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. (2006) (160)
- Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. (2006) (155)
- Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. (2005) (154)
- Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. (2003) (152)
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. (2011) (152)
- New approaches for preventing and treating chronic graft-versus-host disease. (2005) (144)
- Economics of hematopoietic cell transplantation. (2012) (143)
- Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. (2004) (139)
- Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. (2003) (138)
- Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (2004) (137)
- Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. (2013) (136)
- Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. (2016) (134)
- Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (2002) (131)
- Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. (2008) (131)
- Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. (2009) (127)
- Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. (2014) (124)
- Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic GVHD (2012) (120)
- Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. (2009) (117)
- Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. (2012) (116)
- Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. (2005) (112)
- Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. (2009) (111)
- Late effects of blood and marrow transplantation (2017) (110)
- Access to hematopoietic stem cell transplantation (2010) (108)
- Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia. (2006) (108)
- Biomarker Panel for Chronic Graft-Versus-Host Disease. (2016) (107)
- Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. (2013) (107)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report. (2015) (107)
- How I treat late effects in adults after allogeneic stem cell transplantation. (2011) (106)
- Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation (2011) (105)
- Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. (2012) (104)
- Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. (2008) (103)
- Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts (2020) (101)
- Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. (2016) (100)
- Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. (2021) (99)
- Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. (2014) (97)
- Malignant hematologic diseases in adolescents and young adults. (2011) (93)
- Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. (2013) (92)
- Delivering care to long-term adult survivors of hematopoietic cell transplantation. (2012) (92)
- Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. (2014) (89)
- Meeting the challenge of hematologic malignancies in sub-Saharan Africa. (2012) (89)
- Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. (2012) (89)
- Treatment of chronic graft-versus-host disease: Past, present and future (2011) (88)
- Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation. (2014) (88)
- Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (2016) (88)
- End points to establish the efficacy of new agents in the treatment of acute leukemia. (2007) (87)
- Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia (2014) (87)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report. (2017) (87)
- Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease (2009) (86)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report. (2015) (86)
- A survey of diagnosis, management, and grading of chronic GVHD. (2002) (85)
- Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. (2014) (85)
- Validation of measurement scales in ocular graft-versus-host disease. (2012) (83)
- Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (2005) (82)
- Late cardiovascular complications after hematopoietic cell transplantation. (2014) (82)
- Racial and ethnic disparities in hematologic malignancies. (2017) (82)
- Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (2014) (82)
- Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. (2010) (81)
- Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. (2018) (81)
- Management of important adverse events associated with inotuzumab ozogamicin: expert panel review (2018) (80)
- Resilience, health, and quality of life among long‐term survivors of hematopoietic cell transplantation (2015) (79)
- HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research. (2015) (79)
- CHRONIC MYELOGENOUS LEUKAEMIA (2000) (79)
- Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. (2013) (78)
- Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. (2011) (77)
- Unrelated Donor Bone Marrow Transplantation for Chronic Myelogenous Leukemia: A Decision Analysis (1997) (76)
- Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. (2004) (76)
- Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study (2012) (75)
- Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia (2007) (74)
- Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease. (2013) (74)
- Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (2003) (74)
- Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (2014) (73)
- Transplantation's greatest challenges: advances in chronic graft-versus-host disease. (2007) (72)
- Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. (2014) (72)
- Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. (2015) (71)
- Increased BCR responsiveness in B cells from patients with chronic GVHD. (2014) (70)
- The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. (2010) (69)
- Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor-T Cell Therapy. (2019) (67)
- A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation (2015) (67)
- Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. (2006) (66)
- Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions (2018) (66)
- Bortezomib is associated with better health‐related quality of life than high‐dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study (2008) (65)
- Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation (2004) (64)
- Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells. (2016) (64)
- Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. (2017) (64)
- Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. (2010) (63)
- Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation (2017) (63)
- Private Cord Blood Banking: Experiences and Views of Pediatric Hematopoietic Cell Transplantation Physicians (2009) (63)
- Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. (2014) (62)
- Optimistic expectations and survival after hematopoietic stem cell transplantation. (2003) (61)
- HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category. (2010) (59)
- Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation (2012) (58)
- Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life. (2015) (58)
- Clinical evaluation of oral chronic graft-versus-host disease. (2008) (58)
- Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant. (2016) (58)
- Patient‐reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902) (2016) (57)
- A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. (2011) (57)
- Palliative and End-of-Life Care for Patients With Hematologic Malignancies. (2020) (57)
- Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. (2012) (54)
- Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study (2021) (54)
- Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. (2011) (54)
- Individual physician practice variation in hematopoietic cell transplantation. (2008) (53)
- Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation (2016) (51)
- Pilot Study of Patient and Caregiver Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation (2012) (50)
- One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. (2011) (50)
- Variation in supportive care practices in hematopoietic cell transplantation. (2008) (50)
- Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. (2007) (49)
- Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. (2010) (49)
- Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease (2014) (49)
- Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. (2011) (49)
- Pretransplantation Supportive and Palliative Care Consultation for High-Risk Hematopoietic Cell Transplantation Patients. (2016) (48)
- Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium (2011) (48)
- Patient-reported outcomes and health status associated with chronic graft-versus-host disease (2018) (47)
- Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation. (2010) (47)
- Clinical benefit of response in chronic graft-versus-host disease. (2012) (47)
- 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series. (2005) (47)
- The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. (2013) (46)
- Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. (2008) (46)
- Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs. (2002) (45)
- Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. (2018) (45)
- Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. (2009) (45)
- Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. (2011) (45)
- Patients' reflections on communication in the second-opinion hematology-oncology consultation. (2009) (44)
- Biology of Blood and Marrow Transplantation (2015) (44)
- Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (2015) (44)
- Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS) (2016) (44)
- An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease. (2017) (43)
- Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. (2014) (43)
- Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal. (2019) (43)
- ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease (2021) (42)
- National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. (2015) (42)
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. (2007) (42)
- Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia. (2014) (41)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report (2021) (40)
- Centralized patient‐reported outcome data collection in transplantation is feasible and clinically meaningful (2017) (40)
- Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. (2017) (40)
- Time to consider HPV vaccination after allogeneic stem cell transplantation. (2010) (40)
- Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. (2020) (39)
- Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. (2016) (39)
- Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. (2010) (38)
- Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft‐versus‐host disease (2011) (38)
- Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies (2018) (37)
- Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors. (2014) (37)
- Information giving and receiving in hematological malignancy consultations (2012) (36)
- PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS (2011) (36)
- Patient-reported outcomes in acute myeloid leukemia: Where are we now? (2017) (35)
- ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. (2011) (35)
- Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium. (2013) (35)
- Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation (2011) (34)
- Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. (2015) (34)
- Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease. (2016) (34)
- PROMIS measures can be used to assess symptoms and function in long‐term hematopoietic cell transplantation survivors (2018) (34)
- Fluticasone, Azithromycin, And Montelukast (FAM) Therapy In Reducing Corticosteroid Exposure In Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplant – A Case Series Of Eight Patients (2010) (33)
- Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens. (2013) (33)
- Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia (2020) (33)
- Advance care planning in patients undergoing hematopoietic cell transplantation. (2007) (33)
- Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease. (2015) (32)
- Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia (2013) (32)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. (2021) (32)
- Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study (2011) (31)
- Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis. (2018) (31)
- Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. (2013) (31)
- HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide. (2021) (31)
- Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease (2014) (31)
- Variation in management of immune suppression after allogeneic hematopoietic cell transplantation. (2011) (31)
- A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801 (2018) (30)
- Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. (2019) (30)
- Financial Impact of Allogeneic Hematopoietic Cell Transplantation on Patients and Families over 2-years: Results from a Multicenter Pilot Study (2016) (30)
- Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients. (2018) (29)
- Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1 (2014) (29)
- Positive Psychological Constructs and Health Outcomes in Hematopoietic Stem Cell Transplantation Patients: A Systematic Review. (2019) (29)
- Have we made progress in the management of chronic graft-vs-host disease? (2010) (29)
- Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease. (2017) (29)
- Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic graft-versus-host disease: An international survey of the EBMT-NCI Chronic GVHD Task Force (2013) (29)
- Acute graft versus host disease after orthotopic liver transplantation (2012) (29)
- Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. (2010) (28)
- Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease (2015) (28)
- Sentinel Lymph Node Biopsy for Evaluation and Treatment of Patients With Merkel Cell Carcinoma (2006) (28)
- Quality of life from the perspective of the patient with acute myeloid leukemia (2018) (28)
- Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. (2015) (27)
- Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. (2011) (27)
- Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis (2017) (27)
- ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. (2018) (27)
- Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation. (2016) (27)
- Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease. (2018) (27)
- Physician communication styles in initial consultations for hematological cancer. (2013) (27)
- Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease. (2012) (27)
- Replication of associations between genetic polymorphisms and chronic graft-versus-host disease. (2016) (26)
- Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia (2018) (25)
- Advance Care Planning Among Hematopoietic Cell Transplant Patients and Bereaved Caregivers (2014) (24)
- Transplant Center Characteristics And Survival After Allogeneic Hematopoietic Cell Transplantation In Adults (2019) (24)
- Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life. (2014) (24)
- Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia. (2016) (24)
- Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. (2018) (24)
- Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers. (2019) (24)
- Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation. (2002) (23)
- Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study (2020) (23)
- Coping styles, health status and advance care planning in patients with hematologic malignancies (2011) (22)
- Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials. (2008) (22)
- Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life. (2015) (22)
- Intensive Versus Non-Intensive Induction Therapy for Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) Using Two Different Novel Prognostic Models (2016) (22)
- Graft-versus-host disease: state of the science. (2013) (21)
- Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD (2014) (21)
- Intensity of End-of-Life Care for Patients with Hematologic Malignancies and the Role of Race/Ethnicity. (2018) (21)
- The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial (2018) (20)
- A combined biomarker and clinical panel for chronic graft versus host disease diagnosis (2016) (20)
- Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease. (2011) (20)
- Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation (2018) (20)
- Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes. (2018) (19)
- Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium (2021) (19)
- Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation (2018) (19)
- Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study. (2016) (19)
- Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research (2016) (19)
- Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America. (2019) (18)
- Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. (2016) (18)
- In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance. (2018) (18)
- Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions. (2020) (18)
- Number of HLA mismatched eplets is not associated with major outcomes in haploidentical transplantation with post-transplantation cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. (2021) (18)
- Analysis of gastrointestinal and hepatic chronic grant-versus-host disease manifestations on major outcomes (2013) (18)
- Chronic graft-versus-host disease. (2000) (18)
- Blood and marrow transplant clinical trials network state of the Science Symposium 2014. (2015) (18)
- MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Mar (2017) (18)
- Patient‐hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study (2019) (17)
- Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure. (2018) (17)
- Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. (2018) (17)
- Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial (2014) (17)
- Telomere Length Calibration from qPCR Measurement: Limitations of Current Method (2018) (17)
- Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation (2017) (17)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report. (2021) (17)
- Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress (2018) (16)
- Genetic risk factors for sclerotic graft-versus-host disease. (2014) (16)
- Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews. (2016) (16)
- Integrative Medicine in Hematology / Oncology : Benefits , Ethical Considerations , and Controversies (2005) (16)
- Confounding Factors Affecting the National Institutes of Health (NIH) Chronic Graft-Versus-Host Disease Organ-Specific Score and Global Severity (2016) (15)
- An update on how to treat chronic GVHD. (2003) (15)
- Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia (2012) (14)
- Providing personalized prognostic information for adult leukemia survivors. (2013) (14)
- Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts. (2008) (14)
- Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients (2019) (14)
- Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213) (2020) (14)
- Disability Related to Chronic Graft-Versus-Host Disease. (2020) (14)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report. (2021) (14)
- Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population. (2005) (14)
- Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis. (2014) (13)
- Age and gender differences in financial distress among hematopoietic cell transplant survivors (2020) (13)
- Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes. (2017) (13)
- Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data. (2016) (13)
- Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation. (2009) (13)
- Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis. (2019) (13)
- Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life. (2020) (13)
- CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results (2017) (13)
- A Couple-Based Communication Intervention for Hematopoietic Cell Transplantation Survivors and Their Caregiving Partners: Feasibility, Acceptability, and Change in Process Measures. (2018) (13)
- Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia (2019) (13)
- Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation (2021) (13)
- Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia. (2020) (13)
- Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment. (2012) (13)
- Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD). (2009) (12)
- Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial. (2015) (12)
- Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation. (2019) (12)
- Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis. (2019) (12)
- No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia (2017) (11)
- Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia. (2020) (11)
- Feasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: a pilot randomized controlled trial (2020) (11)
- Translation of Clinical Research into Practice: An Impact Assessment of the Results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization. (2018) (11)
- Narrow‐band UVB phototherapy for management of oral chronic graft‐versus‐host disease (2015) (11)
- Patient-reported outcomes for acute graft-versus-host disease prevention and treatment trials. (2010) (11)
- Time to Insurance Approval in Private and Public Payers Does Not Influence Survival in Patients Who Undergo Hematopoietic Cell Transplantation. (2016) (10)
- Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study. (2018) (10)
- Carfilzomib for treatment of refractory chronic graft vs. host disease: A Chronic GVHD Consortium pilot phase II trial. (2020) (10)
- Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients. (2019) (10)
- Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. (2005) (10)
- Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia. (2020) (10)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report. (2021) (10)
- Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. (2021) (10)
- Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation. (2020) (10)
- CMV exposure drives long-term CD57+ CD4 memory T cell inflation following allogeneic stem cell transplant. (2021) (10)
- The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports. (2021) (10)
- Measuring quality of life in acute myeloid leukemia: limitations and future directions (2016) (10)
- Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia. (2018) (10)
- Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: A National Cancer Database Study (2018) (10)
- Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 (2014) (9)
- Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). (2017) (9)
- Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft Versus Host Disease. (2021) (9)
- Improving quality of life in hematopoietic stem cell transplant survivors through a positive psychology intervention. (2020) (9)
- Impact of Comorbidities at Diagnosis of Acute Myeloid Leukemia on One-Year Mortality (2015) (9)
- Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection. (2018) (9)
- Costs of Second Allogeneic Hematopoietic Cell Transplantation (2013) (9)
- Late infectious complications in hematopoietic cell transplantation survivors: a population-based study. (2020) (9)
- Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum. (2016) (9)
- HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment. (2021) (9)
- Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia (2019) (9)
- The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease. (2019) (8)
- Decisional involvement and information preferences of patients with hematologic malignancies. (2020) (8)
- Supporting Adolescents Exposed to Disasters. (2008) (8)
- Peripheral Blood Progenitor Cell (PBPC) Transplantation from Haploidentical Donors Following Reduced Intensity Conditioning (RIC) for High-Risk Hematologic Malignancies (2012) (8)
- Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD (2018) (8)
- Health-related quality of life (HRQL) associated with bortezomib compared with high-dose dexamethasone in relapsed multiple myeloma (MM): Results from APEX study (2005) (8)
- Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia. (2017) (8)
- Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment (2020) (8)
- JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance. (2005) (8)
- The Clinical Significance of Matching for Alleles at the Low Expression HLA Loci DP, DQ and DRB3/4/5 in Unrelated Hematopoietic Stem Cell Transplantation (2008) (8)
- Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation. (2006) (8)
- Sexual functioning in long-term survivors of hematopoietic cell transplantation. (2020) (8)
- KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results (2018) (8)
- Development and validation of the AML-QOL: a quality of life instrument for patients with acute myeloid leukemia (2020) (8)
- A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials (2011) (8)
- Influence of Metabolic Traits and Lifestyle Factors on Cardiovascular Disease After Hematopoietic Cell Transplantation (2012) (8)
- KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208) (2019) (8)
- Influence of Metabolic Traits and Lifestyle Factors on Cardiovascular Disease After Hematopoietic Cell Transplantation (2012) (8)
- Ixazomib for Treatment of Refractory Chronic Graft Vs. Host Disease: A Chronic Gvhd Consortium Phase II Trial (2019) (8)
- The Clinical and PRV-1 Expression Phenotype of Wild-Type, Heterozygous, and Homozygous JAK2 V617F in Polycythemia Vera. (2005) (7)
- Ixazomib for treatment of refractory chronic graft vs. host disease: A Chronic GVHD Consortium phase II trial: Ixazomib for chronic GVHD treatment. (2020) (7)
- Severity, Course, and Predictors of Sleep Disruption Following Hematopoietic Cell Transplantation: A Secondary Data Analysis from the BMT CTN 0902 Trial (2018) (7)
- Pre‐transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia (2019) (7)
- Anterior segment optical coherence tomography evaluation of ocular graft-versus-host disease: a case study. (2015) (7)
- Outcomes Research in Hematopoietic Cell Transplantation (2007) (7)
- Multi-Site 11-Year Experience of Less-Intensive versus Intensive Therapies in Acute Myeloid Leukemia. (2021) (7)
- What We Have Learned and What We Need to Know (2006) (7)
- Reliability and Validity of the Modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom Scale (2020) (7)
- Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes. (2022) (7)
- Tips for success as an academic clinical investigator. (2013) (7)
- Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. (2022) (7)
- The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age. (2011) (7)
- Comprehensive Virome-wide Antibody Responses by Systematic Epitope Scanning After Hematopoietic Cell Transplantation. (2019) (7)
- Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders (2018) (6)
- Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study. (2020) (6)
- Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation (2008) (6)
- Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach (2020) (6)
- Oral Mucositis Incidence and Severity after Methotrexate and Non-Methotrexate Containing GVHD Prophylaxis Regimens. (2004) (6)
- Time-to-event analysis when the event is defined on a finite time interval (2019) (6)
- Distress in a Pandemic: Association of the Coronavirus Disease-2019 Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation (2021) (6)
- Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study. (2021) (6)
- Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes. (2017) (6)
- Early posttransplant spirometry is associated with the development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplant. (2019) (6)
- Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation. (2015) (6)
- Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians. (2016) (6)
- Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. (2021) (6)
- Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. (2016) (6)
- Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes (2016) (6)
- Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States (2020) (6)
- Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant (2020) (6)
- A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: The PATH proof-of-concept trial (2021) (6)
- Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023 (2020) (6)
- Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. (2013) (6)
- Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease (2013) (6)
- Late critical problems in transplantation: an historical perspective. (2008) (6)
- Clinical evaluation of oral chronic graft-versus-host disease (2006) (5)
- Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation (2021) (5)
- Psychological Correlates of Having Advance Care Planning in Patients with Hematological Malignancies. (2009) (5)
- Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. (2022) (5)
- Preservation of fertility in patients with cancer. (2009) (5)
- High Levels of Early Donor Chimerism and Treatment-Responsive Disease Predict Improved Progression-Free Survival Following Non-Myeloablative Transplantation for Advanced CLL. (2005) (5)
- Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (2016) (5)
- Who enrolls in an online cancer survivorship program? Reach of the INSPIRE randomized controlled trial for hematopoietic cell transplantation survivors. (2020) (5)
- A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation. (2022) (5)
- Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths. (2019) (5)
- Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population. (2016) (4)
- Three FDA-approved therapies for chronic GVHD. (2022) (4)
- Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia. (2021) (4)
- Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia (2021) (4)
- Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT. (2021) (4)
- Facilitators of Successful Return to Work in 1-5 Year Post-HCT Survivors (2021) (4)
- HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: A Cibmtr Analysis (2013) (4)
- Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation (2018) (4)
- Relevance of plasma matrix metalloproteinase-9 for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation: Plasma MMP-9 in BOS. (2021) (4)
- The disposable bandage soft contact lenses therapy and anterior segment optical coherence tomography for management of ocular graft-versus-host disease (2021) (4)
- The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index. (2019) (4)
- Patient-reported outcomes in multiple myeloma. (2004) (4)
- Reliability and validity of the modified 7-day Lee Chronic-versus-Host Disease Symptom Scale: Modified Lee chronic GVHD symptom scale. (2019) (4)
- Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse Blood Marrow (2010) (4)
- Carfilzomib for Treatment of Refractory Chronic Gvhd: A Chronic GVHD Consortium Pilot Trial (2019) (4)
- Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone. (2004) (4)
- Patient-Physician Communication about Hematologic Malignancies. (2004) (4)
- Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML). (2007) (4)
- Yin and Yang of Psychological Health in the Cancer Experience: Does Positive Psychology Have a Role? (2022) (4)
- Sirolimus and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation. (2004) (4)
- Randomized trial of an inpatient palliative care intervention in patients hospitalized for hematopoietic stem cell transplantation (HCT). (2016) (4)
- Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. (2009) (4)
- Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT) (2015) (4)
- Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival (2021) (4)
- Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplant Survivors: An Initial Survey. (2020) (4)
- Hematopoietic cell transplantation (HCT) in older patients with acute myeloid leukemia (AML). (2016) (4)
- Development of a disease-specific measure of quality of life in myelodysplastic syndromes (MDS): The “QUALMS-1”. (2012) (4)
- Oral mucositis incidence and severity after methotrexate- and non-methotrexate-containing GVHD prophylaxis regimens (2005) (3)
- Chronic GvHD NIH Consensus Project Biology Task Force: Evolving path to personalized treatment of chronic GvHD. (2022) (3)
- Sirolimus and tacrolimus as graft-versus-host disease prophylaxis in allogeneic stem cell transplantation: The Dana Farber Cancer Institute experience (2005) (3)
- Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia (2016) (3)
- Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802 (2017) (3)
- 5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood (2015) (3)
- Determinants of receipt of hematopoietic cell transplantation (HCT) in younger patients with acute myeloid leukemia (AML). (2016) (3)
- Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score (2016) (3)
- Pre-transplant Exercise and Hematopoietic Cell Transplant Survival: a secondary analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902) (2016) (3)
- Estimation and inference for semi-competing risks based on data from a nested case-control study (2020) (3)
- Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis (2010) (3)
- Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR (2010) (3)
- Association of plasma CD 163 concentration with de novo-onset chronic graft-versus-host disease (2017) (3)
- Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation (2019) (3)
- Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes. (2020) (3)
- Rituxan for steroid-refractory chronic GVHD (2005) (3)
- Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors. (2021) (3)
- Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia (2021) (3)
- KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results (2019) (3)
- Population frequency of Fanconi pathway gene variants and their association with survival after hematopoietic cell transplant for severe aplastic anemia. (2020) (3)
- Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR) (2013) (3)
- Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease (2022) (3)
- Self-Reported Depression and Anxiety By Patients with Chronic Graft-Versus-Host Disease Identify a Group with Worse Quality of Life, Symptoms, and Functional Status (2016) (3)
- Gender differences in question-asking at the 2019 American Society of Hematology Annual Meeting. (2020) (3)
- Confounding Factors Affecting the National Institutes of Health (NIH) Chronic GVHD Organ-Specific Score and Global Severity (2014) (2)
- Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles. (2007) (2)
- Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis. (2004) (2)
- Safety, Tolerability, and Efficacy of Axatilimab, a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment (2021) (2)
- An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm AML patients. (2022) (2)
- Non-Relapse Mortality Among Patients Diagnosed with Chronic Graft-Versus-Host Disease: An Updated Analysis from the Chronic Gvhd Consortium (2021) (2)
- Utilization Of Preventive Care Services By Hematopoietic Cell Transplant Survivors (2010) (2)
- Characterization of Distinct Molecular Signatures in Myeloproliferative Diseases with the JAK2V617F Mutation and Wild Type JAK2. (2005) (2)
- Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD) (2018) (2)
- Determinants of quality of life in patients with acute myeloid leukemia. (2017) (2)
- Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study. (2019) (2)
- Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple Myeloma. (2019) (2)
- Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease. (2019) (2)
- Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial (2014) (2)
- Direct-to-consumer advertising in oncology: a content analysis of print media. (2007) (2)
- Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study (2021) (2)
- Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation (2016) (2)
- Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning. (2005) (2)
- Guidelines and Support for Return to Work after Hematopoietic Cell Transplantation (2019) (2)
- Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies. (2022) (2)
- Increased BLNK and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets (2013) (2)
- Plasma Osteopontin Is a Biomarker Specifically Associated with Bronchiolitis Obliterans Syndrome after HCT (2016) (2)
- Genomic Mechanisms of SES-Related Outcome Disparities in Hematopoietic Cell Transplantation (2018) (2)
- Advance care planning (ACP) prior to hematopoeitic stem cell transplantation (HSCT) in patients with cancer is associated with improved survival (2007) (2)
- High Levels of Donor Chimerism Early after Non-Myeloablative Transplantation Predictive of Overall and Progression Free Survival but Not Risk of Acute Graft Versus Host Disease for Patients with AML or MDS. (2004) (2)
- Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation (2015) (2)
- Stratification of Allogeneic Hematopoietic Cell Transplant Patients by Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score (2017) (2)
- Machine Learning Reveals Patient Phenotypes and Stratifies Outcomes in Chronic Graft-Versus Host Disease (2018) (2)
- A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (2)
- Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation (2021) (2)
- A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies (2013) (2)
- Chronic Graft-Versus-Host Disease, Non-Relapse Mortality and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A CIBMTR Analysis. (2021) (2)
- Analysis of Single Nucleotide Polymorphisms (SNP) Donor/Recipient Mismatches in the Gamma Block of the Major Histocompatibility Complex (MHC) and Their Association with Hematopoietic Cell Transplantation (HCT) Outcomes: A CIBMTR Study (2018) (2)
- Genetics of HLA peptide presentation, and impact on outcomes in HLA-matched allo-HCT. (2021) (2)
- study International Bone Marrow Transplant Registry (IBMTR) prospective Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and systems: a joint Société Française de Greffe de Moëlle et Thérapie Prospective evaluation of 2 acute graft-versus-host (GVHD) grading (2013) (2)
- Re: chronic graft-versus-host disease. (2003) (2)
- HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis From The CIBMTR (2015) (2)
- Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis (2022) (2)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy (2021) (1)
- PS1533 KD025–208: A PHASE 2A TRIAL OF KD025 FOR PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) – UPDATED SAFETY AND EFFICACY (2019) (1)
- Identification of Modifiable Factors Associated with Lower Adherence to Preventive Care Practices In HCT Survivors. (2010) (1)
- Impact of Chronic Graft-Versus-Host Disease on Patients’ Quality of Life, Employment, Productivity, Income, and Caregivers (2021) (1)
- Clonal Alterations and Survival after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia (2018) (1)
- Failure-Free Survival After Initial Systemic Treatment Of Chronic GVHD (2013) (1)
- Prognostic understanding in hematologic malignancies: A multicenter longitudinal study. (2019) (1)
- Insufficient Evidence for Association of NOD2/CARD15 or Other Inflammatory Bowel Disease-Associated Markers with Gvhd or Other Outcomes in T-Replete, Unrelated Donor Transplantation Facilitated by the NMDP (2008) (1)
- Quality of Life and Chronic Gvhd Severity According to the NIH Criteria: Results From the Chronic Gvhd Consortium (2010) (1)
- Community Health Status and Its Association with Patient Outcome Post Allogeneic Hematopoietic Cell Transplantation [HS1]2500 Character Limit of Body of Abstract without Spaces or Title (2019) (1)
- Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia (2021) (1)
- [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. (2014) (1)
- Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients (Pts) with Glucocorticoid-Refractory Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study (2021) (1)
- Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation. (2009) (1)
- The Impact of Age on Quality of Life, Functional Status, and Overall Survival in Patients with Moderate-Severe Chronic Graft-Versus-Host Disease (2014) (1)
- The Association between Transplant-Associated Thrombotic Microangiopathy and Calcineurin Inhibitor and Sirolimus Levels (2018) (1)
- KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208) (2020) (1)
- Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease. (2019) (1)
- Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant (2022) (1)
- HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults. (2007) (1)
- A Predictive Model Using Telomere Length to Select Optimal Donors for Hematopoietic Stem Cell Transplant (HCT) for Acute Leukemia (2015) (1)
- Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities (2022) (1)
- Employment, Insurance and Financial Experiences of Patients with Chronic Graft-Versus-Host Disease (2018) (1)
- Durable Discontinuation of Immunosuppressive Therapy (IST): Clinical Results from the Chronic GvHD Consortium (2021) (1)
- The Impact of Oral Chronic Graft-Versus-Host Disease on Global Measures of Quality of Life (2015) (1)
- Development and Preliminary Usability and Accuracy Testing of the EBMT Gvhd App to Support Graft Versus Host Disease Diagnosis and Scoring According to NIH Criteria, By the EBMT Complications and Quality of Life Working Party (2015) (1)
- Successful Tolerance Induction of Lung Allografts in Non-Human Primates.: Abstract# 2946 (2014) (1)
- Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-Term Survivors (2020) (1)
- Tips for writing successful patient-oriented research career development awards. (2010) (1)
- Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients (2015) (1)
- HLA-Mismatch Is Associated with Worse Outcomes after Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr Analysis (2014) (1)
- Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study (2022) (1)
- HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report (2006) (1)
- Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies. (2022) (1)
- Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors. (2022) (1)
- Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression (2022) (1)
- Treg Promoting Immunosuppression and Non-Immunogenic Donor Antigen Delivery in a Non-Human Primate Islet Transplant Model.: Abstract# 2201 (2014) (1)
- Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease (2010) (1)
- Post-Hematopoietic Cell Transplantation Return to Work Support: A Survey of 1-5 Year Survivors (2021) (1)
- Early Discharge and Outpatient Management of Adult Patients Following Intensive Induction Chemotherapy for MDS and Non-APL AML: A Pilot Study (2010) (1)
- Analysis of Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) in Mismatched Unrelated Donor Hematopoietic Stem Cell Transplants (HCT): A Center for International Blood and Marrow Transplant Research (CIBMTR) Cohort Study (2017) (1)
- Thrombotic microangiopathy increases the risk of chronic kidney disease but not overall mortality in long-term transplant survivors. (2021) (1)
- Natural killer cell alloreactivity predicted by killer cell immunoglobulin-like receptor ligand mismatch does not impact engraftment in umbilical cord blood and haploidentical stem cell transplantation. (2022) (1)
- BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406 (2013) (1)
- Feasibility of Centralized Electronic Patient-Reported Outcome (ePRO) Collection By an Outcome Registry, a CIBMTR Study of Patients on the Centers for Medicaid & Medicare Coverage with Evidence Development (CMS CED) Myelodysplasia Protocol (2020) (1)
- Multi-State Modeling Identifies Determinants of Successful Immune Suppression Discontinuation: Secondary Analysis of BMT CTN 0201 and 0402 Trials (2017) (1)
- Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT). (2007) (1)
- Quality of Life Issues Post-Transplantation (2008) (1)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy (2021) (1)
- Amphiregulin Modifies the Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN Acute Gvhd Therapy Trials (2018) (1)
- Transplantation Of Peripheral Blood Progenitor Cells (PBPC) As Compared To Bone Marrow (BM) From Unrelated Related Donors For Hematologic Cancers Using Fludarabine-Alkylating Agent Based Reduced Intensity Conditioning Regimens (2013) (1)
- One Antigen HLA-Mismatched Related and 8/8 Allele Matched Unrelated Donors Are Associated with Similar Survival after Hematopoietic Cell Transplantation for Acute Leukemia. (2008) (1)
- Donor KIR Gene Content and KIR-Ligand Matching and Outcomes of Pediatric Patients with JMML Following Unrelated Donor Transplant. (2021) (1)
- transplantation disease prophylaxis in mismatched related donor or unrelated donor Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host (2013) (1)
- HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE: NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report (2015) (1)
- Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium (2011) (1)
- Influence Of Killer Immunoglobulin-Like Receptor (KIR) and HLA Genotypes On Outcomes After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation For Patients With AML and MDS: A Report From The Center For International Blood and Marrow Transplant Research Immunobiology Wo (2013) (1)
- Current practice for screening and management of financial distress at NCCN member institutions. (2019) (1)
- Rare Variant Genetic Association Study for Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Via Whole Exome Sequencing (2021) (1)
- Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas. (2022) (1)
- The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR (2018) (1)
- Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis. (2018) (1)
- Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 (2013) (1)
- Change in NIH Skin Score 0–3 Correlates with Provider- and Patient-Reported Skin Changes and Overall Survival: Results From the Chronic Gvhd Consortium (2011) (1)
- Prevention of Acute GVHD with Sirolimus Does Not Abrogate the Risk of Chronic GVHD. (2004) (1)
- Advance care planning (ACP) among hematopoietic cell transplant (HCT) patients and bereaved caregivers. (2012) (1)
- Single HLA Class I Mismatches with High Peptide Divergence in the Graft-Versus-Host Direction Are Associated with Inferior Survival after 9/10 HLA-Matched UD-HCT: A Retrospective Study from the CIBMTR (2021) (1)
- The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation (2014) (1)
- Frequency and Intensity of Antibody Responses to Antigens Encoded by KDM5D (SMCY) and Other H-Y Genes After Allogeneic Hematopoietic Cell Transplantation, (2011) (1)
- A Biomarker Panel for Chronic Graft-Versus-Host Disease (2015) (1)
- The Impact of Pre-Transplant Depression on Outcomes of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation (2015) (1)
- Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102 (2022) (1)
- Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease (2022) (1)
- IMPACT OF HLA UNIDIRECTIONAL MISMATCHES ON THE OUTCOME OF UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (2012) (1)
- Donor IFNL4 Genotype Is Associated with Transplant-Related Mortality after Unrelated Donor Myeloablative Hematopoietic Cell Transplantation in Patients with Acute Leukemia (2018) (1)
- Donor IFNL4 Genotype Is Associated with Transplant-Related Mortality after Unrelated Donor Myeloablative Hematopoietic Cell Transplantation in Patients with Acute Leukemia (2018) (1)
- Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research. (2023) (1)
- Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease (2015) (1)
- Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials (2022) (1)
- Family Cord Blood Banking: Experience and Views of Pediatric Hematopoietic Stem Cell Transplant Physicians. (2004) (0)
- Differences in Medical Decision Making in Adult and Pediatric Hematopoietic Stem Cell Transplantation (HCT). (2006) (0)
- Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival (2022) (0)
- Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant (2021) (0)
- New Guidelines Help Health Professionals Recognize and Manage Late Complications (2006) (0)
- hematopoietic stem cell transplantation in the United States Association of transplant center and physician factors on mortality after (2011) (0)
- Influence Of Organ Scores On Mortality In Chronic GVHD: Results From The Chronic GVHD Consortium (2013) (0)
- Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant (2020) (0)
- Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS (2018) (0)
- Improving Donor Selection for Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide through Selective HLA-Mis/Matching (2020) (0)
- Prospective Phase Ii Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bos Pathogenesis (2021) (0)
- Comparison of Proposed NIH Response Criteria with Clinician-Reported Changes in Organ-Specific and Overall Response (2011) (0)
- Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (2017) (0)
- Immune Correlates from a Prospective Trial Suggest Leukotriene Signaling and Alternative Macrophage Activation in Clinical Bronchiolitis Obliterans Syndrome (2021) (0)
- Gastrointestinal and Hepatic Involvement in Chronic Gvhd: An Analysis From the Chronic Gvhd Consortium (2012) (0)
- Towards Identifying the Target of Autoimmunity in Aplastic Anemia (2020) (0)
- Patient-reported outcomes and socioeconomic status as predictors of clinical outcomes following hematopoietic stem cell transplantation: A study from the BMT CTN 0902 trial (2016) (0)
- Reliability and validity of the modified 7-day Lee Chronic-versus-Host Disease Symptom Scale (2020) (0)
- Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (2022) (0)
- Lack of association between geographic factors and survival in hematopoietic cell transplantation. (2014) (0)
- Dental Clearance Prior to Allogeneic Hematopoietic Cell Transplantation (2022) (0)
- My Poor Self-Care During the Pandemic (2020) (0)
- transplantation Risk factors for acute GVHD and survival after hematopoietic cell (2012) (0)
- Analysis of Pulmonary Function Change Associated with Sclerotic Chronic Graft Versus Host Disease (ScGVHD) (2017) (0)
- Development, preliminary usability and accuracy testing of the EBMT “eGVHD App” to support graft versus host disease assessment according to NIH criteria – a proof of concept (2016) (0)
- Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of BMT CTN 0902 Data Blood Marrow (2016) (0)
- Predicting C osts o f S tem-Cell T ransplantation (2000) (0)
- Content of Hematologic Malignancies Consultations: Good and Bad News From the HEMA-COMM Study. (2009) (0)
- Autologous transplant survivors: out of the woods? (2005) (0)
- New Strategies for Fungal Infections after Hematopoietic Cell Transplantation : Prevention or Preemption ? (2007) (0)
- HLA Evolutionary Divergence Does Not Predict Relapse and Survival Following Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies (2023) (0)
- Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic Graft vs. Host Disease: A Report of Two Phase I/II Trials (2022) (0)
- Creating a National Cohort of Myeloproliferative Disorders Using the Internet: A Feasibility Study. (2004) (0)
- Allogeneic B Cell Response to H-Y Minor Histocompatibility Antigens after Donor Lymphocyte Infusion Correlates with Disease Response. (2004) (0)
- Chronic Graft-Versus-Host Disease and Its Association with Treatment-Related Mortality, Relapse, Leukemia-Free and Overall Survival After Umbilical Cord Blood Transplantation (UCBT) In Children and Adolescents with Acute Leukemia (2010) (0)
- Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes (2015) (0)
- Cyclosporine Dose Intensity and Risk of Acute Graft- versus-Host Disease: Trough versus Area under the Curve (2010) (0)
- The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort (2013) (0)
- AML-145: Multicenter 11-Year Experience of Outcomes After Intensive Versus Less-Intensive Therapy for Patients with Acute Myeloid Leukemia: Focus on Older and Medically Infirm Patients (2020) (0)
- Recommended Tools for Joint Chronic Graft-Versus-Host Disease: Results From the Chronic Gvhd Consortium (2012) (0)
- Risk Factors for Late Cardiovascular Morbidity and Mortality After Hematopoietic Cell Transplantation (2011) (0)
- OI0447 Narrow-band UV-B phototherapy for management of oral chronic graft-vs-host disease (2014) (0)
- Patient-Reported Outcomes Associated With Chronic GVHD (2017) (0)
- Association of Socioeconomic Status (SES) with Chronic Graft-Versus-Host Disease (cGVHD) Outcomes (2017) (0)
- Anterior Segment OCT Evaluation of Ocular Graft-versus-Host Disease (2013) (0)
- TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease (2013) (0)
- Pre-HCT Telomere Abnormalities and Mortality after Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia (2019) (0)
- Utility of Grip Strength and 2 Minute Walk Test in Chronic GVHD Assessment: An Analysis From the Chronic GVHD Consortium (2013) (0)
- Haploidentical Versus Matched Unrelated Donor Transplants for Lymphomas Using Post-Transplant Cyclophosphamide: A Joint CIBMTR/EBMT Study (2022) (0)
- Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr (2013) (0)
- Effect of Heterozygosity of Human Leukocyte Antigen on Outcomes Following Allogeneic Hematopoietic Cell Transplant for Myeloid and Lymphoid Malignancies (2019) (0)
- Tandem BMT meetings workshop descriptions (2004) (0)
- Chromosomal Aberrations in Pre-HCT Blood Samples and Outcomes after Transplantation in Patients with Myelofibrosis (2020) (0)
- MATERIALS AND METHODS Patients Patients with active cGVHD following allogeneic stem cell transplantation at the Dana-Farber Cancer Institute and the Brigham and Women ’ s Hospital Stem Cell Transplant (2002) (0)
- Impact of HLA Molecular Mismatch on Haploidentical Hematopoietic Stem Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study (2021) (0)
- Chronic Graft versus Host Disease: Interdisciplinary Management: Risk Factors and Predictive Models for Chronic Graft versus Host Disease (2009) (0)
- Late infectious complications in hematopoietic cell transplantation survivors. (2019) (0)
- age hematopoietic cell transplantation for patients older than 50 years of Comparative outcome of nonmyeloablative and myeloablative allogeneic (2013) (0)
- Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients (2017) (0)
- Decline in Chronic Gvhd (cGVHD) at Fred Hutchinson Cancer Center (FHCC) between 2005 and 2019 (2023) (0)
- Chronic Gvhd Global Severity According to NIH Consensus Criteria: Results From the Chronic Gvhd Consortium (2010) (0)
- Gene Expression in CD4+ T Cells of Patients With and Without Chronic Graft-Vs-Host Disease (cGVHD) (2011) (0)
- Genotype cross-reactive antibody responses to hepatitis C virus (2012) (0)
- Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplant and investigation into BOS pathogenesis. (2022) (0)
- Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial (2019) (0)
- Heath-related Quality of Life in Double Umbilical Cord Blood vs. Haploidentical Marrow Transplantation: a QOL Analysis Report of BMT CTN 1101. (2023) (0)
- Time To Insurance Approval Of Hematopoietic Stem Cell Transplantation (HSCT) Between Private and Public Payers Is Not Associated With Survival (2013) (0)
- Donor Lymphocyte Cell-Specific Telomere Length and Causes of Death after Unrelated Hematopoietic Cell Transplant in Patients with Marrow Failure (2017) (0)
- Higher Proportions of IFNg-Producing T Cells, CD56bright NK Cells and Immature B Cells in the Lymphocytes of G-CSF Stimulated Donor Grafts Are Associated with Less Chronic Gvhd After HSCT: Results From the Canadian BMT Group 0601 Randomized, Phase III Trial (2012) (0)
- A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease (2015) (0)
- Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults (2013) (0)
- HLA Genotyping Does Not Predict Outcomes in Hematopoietic Cell Transplantation (alloHCT) (2020) (0)
- Changes in CD4+ T Cells and Regulatory T Cells (Treg) in Chronic Graft-Versus-Host Disease (cGVHD) (2011) (0)
- Comorbidity Burden in Patients with Chronic Graft Versus Host Disease (2014) (0)
- Prognostic Impact of Pre-Transplant Chromosomal Aberrations Detected By SNP-Array in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant for Acute Myeloid Leukemia (2020) (0)
- Understanding Physicians' Perspectives About Translating Research Into Clinical Practice: Example of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0201 Results (2017) (0)
- disease New approaches for preventing and treating chronic graft-versus-host (2005) (0)
- Racial Disparities in End-of-Life Care Planning and Hospital Utilization: A Single Center Retrospective Study (2017) (0)
- chronic GVHD Evaluation of NIH consensus criteria for classification of late acute and (2009) (0)
- transplantation How I treat late effects in adults after allogeneic stem cell (2014) (0)
- Title : " Risk Score for Veno-occlusive Disease After Allogeneic Stem-Cell Transplant " (2017) (0)
- Baseline Physical and Mental Functioning Are Strong Predictors of Post-Stem Cell Transplant Function and Quality of Life. (2004) (0)
- Whole Exome Sequencing in Severe Aplastic Anemia Identifies Unrecognized Inherited Subset with Inferior Survival after Hematopoietic Cell Transplant (2021) (0)
- Series CHRONIC GRAFT-VERSUS-HOST DISEASE Classi fi cation systems for chronic graft-versus-host disease (2016) (0)
- External validation of the HIGH‐2‐LOW model: A predictive score for venous thromboembolism after allogeneic transplant (2022) (0)
- Prevalence and Predictors of Frailty in Patients with Chronic Graft-Versus-Host Disease (2022) (0)
- Erratum to "Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study" [Biol Blood Marrow Transplant 2016;22:1410-1415]. (2017) (0)
- Recipient Pre-HCT Telomere Length and Outcomes after Unrelated Donor HCT for Acute Leukemia (2017) (0)
- Recipient Pre-HCT Telomere Length and Outcomes after Unrelated Donor HCT for Acute Leukemia (2017) (0)
- Late effects of severe acute GVHD on quality of life, medical comorbidities and survival. (2022) (0)
- Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic GVHD (2015) (0)
- Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients? (2013) (0)
- Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic GVHD (2019) (0)
- Reply to A. Heine et al. (2021) (0)
- Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report (2006) (0)
- Reply to J. Schildmann et al. (2020) (0)
- Comparison of methotrexate- versus sirolimus-containing graft-versus-host disease prophylaxis regimens after myeloablative stem cell transplantation (2006) (0)
- allogeneic hematopoietic stem cell transplant recipients: a cohort study invasive fungal infections in -Candida other emerging risk factors of non Infliximab use in patients with severe graft-versus-host disease and (2011) (0)
- Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection (2022) (0)
- A National Multi-Center Randomized Study to Assess the Accuracy, Reliability, and User Satisfaction of the Ebmt Gvhd App in Graft Versus Host Disease Assessment (2018) (0)
- Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD (2014) (0)
- acute leukemia End points to establish the efficacy of new agents in the treatment of (2013) (0)
- Development of a Validated Clinical Risk Score to Predict the Incidence of Acute Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis (2022) (0)
- JAK2 V617F Mutation and Associated Chromosomal Alterations Involving JAK2 in Pre-HCT Blood Samples and Transplant Outcomes in Myelofibrosis Subtypes (2022) (0)
- Long Term Follow Up (LTFU) after Autologous Hematopoietic Cell Transplantation (AHCT) for Lymphoma and Multiple Myeloma: An Analysis of Patient Self-Reported Outcomes of Medical Conditions and Quality of Life (QOL) (2018) (0)
- Adult Cord Blood Transplantation (CBT) Vs. Unrelated Donor Transplantation: A Cost Comparison (2008) (0)
- Genome-Wide Association Study Identifies an Immune-Related Etiology for Severe Aplastic Anemia (2019) (0)
- Cannabis use in hematopoietic transplantation survivors. (2018) (0)
- Chronic Graft versus Host Disease: Interdisciplinary Management: Design of Clinical Trials Testing Treatment for Chronic Graft versus Host Disease (2009) (0)
- MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study (2015) (0)
- Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation. (2023) (0)
- Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial (2022) (0)
- ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report (2006) (0)
- Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia (2016) (0)
- Extended Soft Bandage Contact Lenses Therapy for Ocular Graft-Versus-Host Disease (2013) (0)
- Sclerotic chronic GVHD: you may WANT to block WNT. (2021) (0)
- B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report (2005) (0)
- Recovery A fter S tem-Cell T ransplantation f or Hematologic D iseases (2001) (0)
- Belumosudil for Patients with Chronic Graft-Versus-Host Disease: Combined Analysis of Failure-Free Survival (FFS) in the KD025-208 and Pivotal Rockstar Trials (2021) (0)
- A Retrospective Comparison of Tacrolimus Vs. Cyclosporine for Immunosuppression After Allogeneic Hematopoietic Cell Transplantation with G-CSF-Mobilized Blood Cells (2010) (0)
- Phase II multisite study to evaluate efficacy and safety of single weekly administration of bortezomib (BZ) and dexmethasone (dex) in newly diagnosed multiple myeloma (NDMM) patients (pts). (2010) (0)
- Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients (2022) (0)
- A Review of Oral Chronic Graft-Versus-Host Disease: Considerations for dental hygiene practice. (2022) (0)
- Dose Modification In MDS Pts Receiving Lenalidomide As a Means To Improve Patient Persistence (2013) (0)
- Clinical Relevance of HLA Supertype Matching after Myeloablative Conditioning 7/8 Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Study (2014) (0)
- Identifying Amino Acid Substitution Positions Associated with Day 100 Survival in Unrelated Donor Stem Cell Transplant Using Random Forest Analysis (2008) (0)
- Chronic Graft versus Host Disease: Interdisciplinary Management: Future Directions (2009) (0)
- Health consensus criteria and for chronic graft-versus-host disease according to National Comparative analysis of risk factors for acute graft-versus-host disease (2011) (0)
- HLA-C Mismatch Is Associated with Inferior Outcome after Unrelated Donor Non-Myeloablative Hematopoietic Stem Cell Transplantation. (2005) (0)
- Germline-Somatic Interactions in Myelofibrosis Susceptibility (2021) (0)
- Management of Important Adverse Events Associated with Inotuzumab Ozogamicin in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia (2017) (0)
- The Graying of Clinical Transplantation (2006) (0)
- Impact of Chronic Graft-Versus-Host Disease (GVHD) on Patients' Employment, Income, and Informal Caregiver Burden: Findings From the Living With Chronic GVHD Patient Survey. (2023) (0)
- Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis (2019) (0)
- Humoral and Cellular Immune Response to Sars-Cov-2 Vaccination in Patients with Chronic GVHD (2022) (0)
- What Predicts Agreement about Prognosis Between Patients and Physicians (2011) (0)
- Distress in a pandemic: The association of the coronavirus disease-2019 (COVID-19) pandemic with distress and quality of life in hematopoietic stem cell transplantation (HSCT). (2021) (0)
- Comments on Brazilian workshop model for training investigators in chronic graft-versus-host disease according to the 2005-2006 National Institutes of Health recommendations (2011) (0)
- Psychosocial Evaluation in Allogeneic Hematopoietic Cell Transplantation Recipients (Allo HCT): Psychosocial Assessment of Candidates for Transplant (PACT) As a Tool to Identify High-Risk Patients and Its Association with Transplant Outcomes (2018) (0)
- Impact of Human Leukocyte Antigen (HLA) Alleles on Outcomes of Allogeneic Transplantation (Allo-HCT) for B-Cell Non-Hodgkin Lymphomas (B-NHL); A CIBMTR Analysis (2016) (0)
- Sirolimus and Tacrolimus without Methotrexate as Graft-vs.-Host Disease Prophylaxis after Matched, Unrelated Peripheral Blood Stem Cell Transplantation: Excellent GVHD Control with Low Transplant-Related Morbidity and Mortality. (2005) (0)
- Allogeneic B cell response to H-Y minor histocompatibility antigens after donor lymphocyte infusion correlates with disease response (2005) (0)
- Frailty in Patients with Chronic Graft-versus-Host Disease. (2023) (0)
- Quality-of-Life Issues Posttransplantation (2004) (0)
- HLA Class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated AML. (2023) (0)
- HLA Class I Genotypes with Predicted Strong Binding Affinity to Mutated NPM1 Are Associated with Lower Relapse Risk in Matched Related or Unrelated Transplant for NPM1 Mutated Acute Myeloid Leukemia (2021) (0)
- Pulmonary Symptoms Measured by the NIH Lung Score Predict Overall Survival and Non-Relapse Mortality in Chronic GVHD (2013) (0)
- prednisone does not compromise patient outcomes Initial therapy of acute graft-versus-host disease with low-dose (2009) (0)
- Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201 (2017) (0)
- Translation, Cross Cultural Adaptation and Validation of the Chronic Graft-Versus-Host Disease (cGVHD) Symptom Bother Scale in a Brazilian Population (2013) (0)
- Sensitization to HY-Antigen in Female Donors Was Not Associated with the Post-Transplant HY-IgG Development Nor Clinical Outcomes in Sex-Mismatched Transplantation (2014) (0)
- Health Economics of Steroid Refractory Chronic Graft-Versus-Host-Disease Treatments: Cost-Utility Based Meta-Analysis (2017) (0)
- Patient-Reported Treatment Response in Chronic Graft Vs. Host Disease: Unique Dimension of Clinical Benefit Associated with Failure-Free Survival (2022) (0)
- Correlation of the NIH and Vienna Skin Scores with Provider and Patient-Reported Skin Changes in Chronic Graft-Versus-Host Disease (GVHD). (2009) (0)
- Anti-Thymocyte Globulin for Patients Undergoing Hematopoietic Cell Transplantation from Unrelated Donors: A Randomized, Controlled, Open-Label, Phase 3, Multicentre Trial from Cell Therapy Transplant Canada (2019) (0)
- Sirolimus and Tacrolimus as Graft-vs.-Host Disease Prophylaxis in Allogeneic Stem Cell Transplantation: The Dana-Farber Cancer Institute Experience. (2004) (0)
- Identification of High Risk HLA Class I Amino Acid Substitutions in Hematopoietic Stem Cell Transplantation. (2012) (0)
- Decisional Involvement, Information Preferences, and Prognostic Optimism Among Patients with Hematologic Malignancies (2020) (0)
- Phase II Multicenter Study of Ofatumumab in Combination with Glucocorticoids As a Primary Therapy for Chronic Graft Versus Host Disease (2020) (0)
- Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. (2023) (0)
- The Prevalence and Effects of Frailty in Chronic Graft-Versus-Host Disease (2022) (0)
- Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival (2017) (0)
- Health-Related Quality of Life in a Biologic Assignment Trial of Reduced Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome (2021) (0)
- High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment (2020) (0)
- In Vivo IL-2 administration can abolish tolerance to kidney allografts induced via mixed chimerism in non-human primates: 600 (2012) (0)
- Chronic gvhd dictionary—eurograft cost action initiative consensus report (2022) (0)
- disease: a multicenter study Performance of a new clinical grading system for chronic graft-versus-host (2013) (0)
- Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study (2020) (0)
- Association of Comorbidity Scoring with Outcome in Patients with Chronic Graft Versus Host Disease (2013) (0)
- leukemia Endpoints to establish the efficacy of new agents in the treatment of acute (2013) (0)
- Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis (2022) (0)
- Ethnic Variation in Chronic Graft-Versus-Host Disease (cGVHD) Manifestations (2013) (0)
- Data Monitoring of a Placebo-Controlled Trial of Daclizumab in Acute Graft-Versus-Host Disease (2006) (0)
- BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial (2015) (0)
- A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease (2021) (0)
- Comparison of Characteristics and Outcomes of Trial Participants and Non-participants: Example of Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial (2015) (0)
- Graft-Versus-Leukemia Responses in Chronic Lymphocytic Leukemia (CLL) are Not Influenced by Natural Killer Cell (NK) KIR Immunogenetics: A CIBMTR Analysis (2018) (0)
- Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation. (2005) (0)
- Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT) (2021) (0)
- stem cell transplantation veno-occlusive disease in patients who undergo myeloablative allogeneic Prior gemtuzumab ozogamicin exposure significantly increases the risk of (2013) (0)
- Donor Telomere Length Predicts Recipient Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Bone Marrow Failure Syndromes (2014) (0)
- Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (2021) (0)
- Reg3α As a Biomarker for Risk of Gastro-Intestinal Chronic Graft-Versus-Host Disease (2021) (0)
- Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS) (2016) (0)
- Change of Treatment for Control of Chronic Graft-Versus-Host Disease (cGVHD) as a Time-Dependent Covariate for Nonrelapse Mortality and Survival. (2007) (0)
- Initial Systemic Therapy of Chronic Graft Vs. Host Disease: Analysis of Practice Variation and Failure-Free Survival (2021) (0)
- Oral and Systemic Complications of Myeloma Patients With Bisphosphonate-Induced Osteonecrosis of the Jaw: A Case-Control Study (2011) (0)
- Hematopoietic Cell Transplantation (HCT) Predictions for the Year 2023 (2020) (0)
- Ocular Gvhd: Epidemiology, Risk Factors and Impact on Quality of Life-a Chronic Gvhd Consortium Study (2014) (0)
- Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Not a Singular Entity (2017) (0)
- Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study (2022) (0)
- Inpatient Integrated Palliative and Transplant Care Improves Caregiver Outcomes of Patients Hospitalized for Hematopoietic Stem Cell Transplantation (HCT) (2017) (0)
- Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching (2018) (0)
- Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic GVHD Consortium (2015) (0)
- and costs transplantation for hematologic diseases: clinical outcome, quality of life, Comparison of T-cell depleted and non-T-cell depleted unrelated donor (2013) (0)
- Late Effects and Patient Reported Quality of Life by Donor Source at 3 Years in Patients Surviving at Least 1 Year Following Hematopoietic Stem Cell Transplantation (2018) (0)
- Chronic Graft-Versus-Host Disease (cGVHD), Non-Relapse Mortality (NRM) and Disease Relapse in Older Vs. Younger Adult Recipients of Matched Sibling or Unrelated Donor Allogeneic Peripheral Blood Hematopoietic Cell Transplant (alloHCT): A CIBMTR Analysis (2021) (0)
- The Role of HLA-E Polymorphism in Acute Leukemia Patients Receiving a 10/10 HLA Matched Unrelated HSCT (2018) (0)
- Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms (2022) (0)
- Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Single Nucleotide Polymorphisms Do Not Impact Outcomes After Unrelated Donor Transplant: A Center For International Blood and Marrow Transplant Research Analysis (2013) (0)
- Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR (2015) (0)
- FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation (2016) (0)
- To give or not to give. (2013) (0)
- edorial Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple Myeloma (2019) (0)
- Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes (2012) (0)
- Fatigue in Hematopoietic Stem Cell Transplant Recipients: Impact, Related Factors, and Patient-Reported Mitigation Strategies (2021) (0)
- Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors (0)
- Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation (2011) (0)
- Costs of Complications after Allogeneic Myeloablative Stem Cell Transplantation. (2006) (0)
- Cytomegalovirus Promotes Aberrant Memory CD4 T Cell Differentiation and Immune Function after Allogeneic Stem Cell Transplantation (2020) (0)
- Anti-IL-6R Antibodies Prevent Acute Rejection of Allogeneic Lung Transplants in Monkeys: 1637 (2012) (0)
- Association of Graft-Versus-Host Disease and Immunosuppressive Treatment with Risks of Recurrent Malignancy and Mortality After Allogeneic Hematopoietic Cell Transplantation (2010) (0)
- A Refined Model of HLA-DP Permissiveness Improves Stratification of Acute Graft-Versus-Host Disease Risks after Unrelated Hematopoietic Cell Transplantation: A Retrospective Study from the CIBMTR (2021) (0)
- Pre-Transplant Clonal Mosaicism Is Associated with Increased Relapse and Lower Survival in Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplant (2020) (0)
- Validation of the AML-QOL: A Quality of Life Instrument for Patients with Acute Myeloid Leukemia and Other Aggressive Myeloid Neoplasms (2018) (0)
- Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A CIBMTR Study (2019) (0)
- Prevalence and Factors Associated with Marital Distress among Hematopoietic Cell Transplant Survivors: Results from a Large Cross-sectional Study. (2022) (0)
- Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure data. (2010) (0)
- Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease (2011) (0)
- Transplant-Associated Thrombotic Microangiopathy (TA-TMA) is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal Blood Marrow (2019) (0)
- De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Transplant Blood Samples (2019) (0)
- Interim Analysis of KD025-213: A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) after at Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study; NCT03640481) (2020) (0)
- Association of Pre-Transplant Depression with Clinical Outcomes and Resource Utilization after Allogeneic Hematopoietic Stem Cell Transplantation (2016) (0)
- The ‘EBMT GVHD App' Improves the Accuracy of Graft-Versus-Host-Disease Assessment According to NIH Criteria Compared to Standard Practice (2016) (0)
- Quality of Life in Patients Undergoing Double Umbilical Cord Blood Vs. Haploidentical Marrow Transplantation: A QOL Analysis Report of BMT CTN 1101 (2022) (0)
- The Definition and Importance of Patient-Reported Outcomes (2009) (0)
- Randomized Trial of Inpatient Palliative Care Intervention for Patients Hospitalized for Hematopoietic Stem Cell Transplantation (HCT) (2017) (0)
- Single HLA Class I Mismatches with High Peptide Divergence in the Graft-Versus-Host Direction Are Associated with Inferior Survival after 9/10 HLA- Matched UD-HCT: A Retrospective Study from the CIBMTR (2022) (0)
This paper list is powered by the following services:
Other Resources About Stephanie Lee
What Schools Are Affiliated With Stephanie Lee ?
Stephanie Lee is affiliated with the following schools:
